The equity research house is bullish about its investment case: “We think good market momentum and further market share gains resulting in the ramp-up of new contracts will support sales growth in the coming 5-10 years (CAGR of 10% for 2023-30 and 6% for 2030-35).

“Meanwhile, we model an underlying Ebit CAGR of 13% for 2023-30 and 9% for 2030-35,” which implies a doubling in revenues by 2030, and a doubling in Ebit by mid-2028.

Its prospects are boosted by strong tailwinds ...

Daily News from £12 / mo  ·  includes Daily News

Comment on this article


You must be logged in to post a comment.